Marshall Wace, LLP Maia Biotechnology, Inc. Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 110,467 shares of MAIA stock, worth $123,723. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,467
Previous 16,165
583.37%
Holding current value
$123,723
Previous $29,000
486.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MAIA
# of Institutions
22Shares Held
2.37MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.1MShares$1.24 Million0.0% of portfolio
-
Centric Wealth Management575KShares$643,8850.21% of portfolio
-
Geode Capital Management, LLC Boston, MA271KShares$303,5820.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$87,9430.0% of portfolio
-
State Street Corp Boston, MA75.6KShares$84,6160.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $12.2M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...